1. Home
  2. SYRE vs LGIH Comparison

SYRE vs LGIH Comparison

Compare SYRE & LGIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$33.59

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo LGI Homes Inc.

LGIH

LGI Homes Inc.

HOLD

Current Price

$47.92

Market Cap

1.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
SYRE
LGIH
Founded
2013
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Homebuilding
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
1.2B
IPO Year
2016
2013

Fundamental Metrics

Financial Performance
Metric
SYRE
LGIH
Price
$33.59
$47.92
Analyst Decision
Strong Buy
Hold
Analyst Count
4
5
Target Price
$55.50
$71.13
AVG Volume (30 Days)
745.7K
330.9K
Earning Date
11-04-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
4.53
Revenue
N/A
$1,788,933,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$17.77
P/E Ratio
N/A
$10.74
Revenue Growth
N/A
N/A
52 Week Low
$10.91
$39.70
52 Week High
$35.31
$104.31

Technical Indicators

Market Signals
Indicator
SYRE
LGIH
Relative Strength Index (RSI) 69.14 46.65
Support Level $33.24 $46.73
Resistance Level $35.31 $50.54
Average True Range (ATR) 1.79 2.17
MACD 0.16 -0.36
Stochastic Oscillator 79.12 10.77

Price Performance

Historical Comparison
SYRE
LGIH

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

About LGIH LGI Homes Inc.

LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. The company have seven operating segments ( West, Northwest, Central, Midwest, Florida, Southeast and Mid-Atlantic) that it aggregates into five qualifying reportable segment. Majority of the revenue is generated from Central division segment.

Share on Social Networks: